Annexin-1 modulates repair of gastric mucosal injury.
Annexin-1 is a glucocorticoid-inducible protein that plays an important effector role in the resolution of inflammation and has recently been shown to contribute to the resistance of the stomach to injury. Using an integrated genetic and pharmacological approach, we have tested the hypothesis that annexin-1 contributes to the healing of mucosal injury, given that such injury is accompanied by an inflammatory response, which is often associated with an overexpression of annexin-1 expression. Gastric ulcers were induced in mice through serosal application of acetic acid. Annexin-1 expression during the healing of the ulcers was examined. The effects on gastric ulcer healing of treatment with an annexin-1 mimetic (Ac2-26), an antagonist of the annexin-1 receptor (Boc2), or a glucocorticoid (dexamethasone) were examined. Finally, susceptibility to and healing of indomethacin-induced gastric lesions were compared in wild-type and annexin-1-deficient mice. Expression of annexin-1 was significantly increased in the gastric ulcer margin throughout the healing process. Treatment with an annexin-1 mimetic (Ac2-26) significantly enhanced gastric ulcer healing. In contrast, both dexamethasone and an formyl peptide receptor-like-1 (FPRL-1) antagonist impaired the early phase of ulcer healing. Annexin-1-deficient mice exhibited the same susceptibility as wild-type mice to indomethacin-induced gastric damage, but the healing of that damage was impaired in the former. These data support the hypothesis that annexin-1 contributes significantly to the process of healing of gastric mucosal damage.
Martin
Gary R
GR
Inflammation Research Network, University of Calgary, Calgary, Alberta, Canada.
Perretti
Mauro
M
Flower
Roderick J
RJ
Wallace
John L
JL
D000818:Animals; D017305:Annexin A1 / Q000502:physiology*; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000633:toxicity; D015153:Blotting, Western; D003907:Dexamethasone / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D005753:Gastric Mucosa / Q000473:pathology*; D007150:Immunohistochemistry; D007213:Indomethacin / Q000633:toxicity; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D044042:Receptors, Formyl Peptide / Q000378:metabolism; D013276:Stomach Ulcer / Q000139:chemically induced / Q000473:pathology* / Q000628:therapy
D017305:Annexin A1; D000894:Anti-Inflammatory Agents, Non-Steroidal; D044042:Receptors, Formyl Peptide; C481578:formyl peptide receptor 2, mouse; D003907:Dexamethasone; D007213:Indomethacin